RhumbLine Advisers’s HilleVax HLVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-44,294
| Closed | -$64.2K | – | 4191 |
|
|
2025
Q1 | $64.2K | Sell |
44,294
-2,234
| -5% | -$3.24K | ﹤0.01% | 3516 |
|
|
2024
Q4 | $96.3K | Sell |
46,528
-2,273
| -5% | -$4.71K | ﹤0.01% | 3483 |
|
|
2024
Q3 | $85.9K | Buy |
48,801
+6,143
| +14% | +$10.8K | ﹤0.01% | 3546 |
|
|
2024
Q2 | $617K | Buy |
42,658
+9,073
| +27% | +$131K | ﹤0.01% | 2523 |
|
|
2024
Q1 | $559K | Buy |
33,585
+1,852
| +6% | +$30.8K | ﹤0.01% | 2603 |
|
|
2023
Q4 | $509K | Buy |
31,733
+4,319
| +16% | +$69.3K | ﹤0.01% | 2645 |
|
|
2023
Q3 | $369K | Buy |
27,414
+838
| +3% | +$11.3K | ﹤0.01% | 2803 |
|
|
2023
Q2 | $457K | Buy |
26,576
+3,570
| +16% | +$61.4K | ﹤0.01% | 2744 |
|
|
2023
Q1 | $380K | Buy |
23,006
+1,228
| +6% | +$20.3K | ﹤0.01% | 2536 |
|
|
2022
Q4 | $364K | Buy |
21,778
+3,624
| +20% | +$60.6K | ﹤0.01% | 2601 |
|
|
2022
Q3 | $310K | Buy |
18,154
+1,056
| +6% | +$18K | ﹤0.01% | 2714 |
|
|
2022
Q2 | $187K | Buy |
+17,098
| New | +$187K | ﹤0.01% | 2946 |
|